Balanced dietary supplement compounds fill in the gaps forged by disease and poor nutrition. ODs here would not be the first to have these privileges. Because of fears concerning microbial resistance, companies are developing alternative fluoroquinolones with better bacterial coverage. Optometrists here have relatively unrestricted prescribing privileges, but the state association is also urging ODs to obtain DEA numbers. While typically a temporary condition, practitioners should conduct preoperative testing and take measures to prevent the problem before it starts.
Surgeons share their indications for each procedure and tips on how they reduce complications.
No loss of efficacy over time has been found. Launches, re-launches and rollouts highlighted a good year for the ophthalmic industry. Use of insulin pumps is growing among type 1 patients. ODs may need to work with internists to address other causes. Four practitioners with varying degrees of involvement with this technology share their experiences and make predictions about its place in the optometric practice of the future.